The Incidence and Progression of Myopia: Cohort Study
A Cohort Study on Incidence and Progression of Myopia in a Group of Medical Students
1 other identifier
observational
350
1 country
1
Brief Summary
A cohort study on incidence and progression of myopia in a group of medical students
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2017
CompletedFirst Posted
Study publicly available on registry
August 9, 2017
CompletedStudy Start
First participant enrolled
August 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 19, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 19, 2019
CompletedSeptember 20, 2019
September 1, 2019
1.9 years
August 7, 2017
September 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
refraction
The participants will be measured for their refractive error by optometrist, and observe the rate of progression of myopia
Change from baseline for two years
Interventions
Observation study only, no specific intervention
Eligibility Criteria
First-year medical college student from Zhongshan University
You may qualify if:
- Volunteer subject, , willing to follow the protocol and able to read, comprehend and sign the informed consent form,
- Age between 17 and 23 years
You may not qualify if:
- Vulnerability of the subject,
- Participation in another study which might have an influence on vision or interfere with study assessments,
- Aphakic or pseudophakic (intraocular lens)
- Participants who are wearing ortho-K lenses, or undergone any kind of myopia control treatments or undergone refractive surgery.
- Any current or evolving pathology manifested in the eye or the appendages which might have an influence on vision, or interfere with study assessments (e.g. AMD, glaucoma…),
- Any previous ocular surgery which might have an influence on vision or interfere with study assessments (e.g. iridectomy, refractive surgery…),
- Any untreated and/or uncontrolled systemic condition which might have an influence on vision, or interfere with study assessments (e.g. uncontrolled diabetes, uncontrolled high blood pressure…),
- Any medical treatment or medication which might have an influence on vision or interfere with study assessments (e.g. antidepressants, drugs with atropinic effects…),
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sun Yat-sen Universitylead
- Essilor Internationalcollaborator
Study Sites (1)
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, 510060, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chen xiang
Associate Professor
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 7, 2017
First Posted
August 9, 2017
Study Start
August 15, 2017
Primary Completion
July 19, 2019
Study Completion
September 19, 2019
Last Updated
September 20, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share